Publications

Journal Article
Review
Ppublish 208 citations
Electronic publication date
October 1, 1996

View on Pubmed.gov 8891463 | View on doi.org 10.2165/0000349...

Intra-articular corticosteroids. Guide to selection and indications for use.

Search for publications in this journal Drugs - 52(4):507-14

Abstract

Physicians have used intra- and periarticular corticosteroids for treating a variety of rheumatic diseases for nearly 50 years. Yet publications that have carefully examined the mechanisms of action, the pharmacokinetics and the comparative safety and efficacy of the available agents are sparse. This limits our ability to choose a drug scientifically. Similarly, we know little about the long term outcomes of joints infected with corticosteroids versus those not injected. Highly branched esters of methylprednisolone or triamcinolone are the preferred agents used by American rheumatologists. Pharmacokinetic studies reveal that triamcinolone hexacetonide, the least soluble of all the corticosteroid esters, is retained in the joint for 2 to 3 weeks. Intra-articular corticosteroids may implement their anti-inflammatory effect by down-regulating genetic expression of several pro-inflammatory proteins. A literature review suggests that judicious use of intra- and periarticular corticosteroids is very helpful in temporarily reducing pain and inflammation in musculoskeletal structures and may facilitate increased motion and function in selected cases. Their use in juvenile arthritis also appears to be safe and beneficial. Infection in or about the joint in the chief contraindication to use. Adverse effects are very few but the number of injections per joint should probably be limited to 4 or less per year.

References

Gac Med Mex. 1991 May-Jun;127(3):233-9; discussion 239-40

Arthritis Rheum. 1985 Dec;28(12):1393-401

Clin Sci. 1970 Jan;38(1):123-33

Rheumatol Rehabil. 1980 Nov;19(4):212-7

Cited by 208 citations (total)

Comparative Study Journal Article Research Support, Non-U.S. Gov't

The pharmacokinetics of the weakly protein-bound anionic compound diatrizoate in serum and synovial fluid of the horse.

Electronic publication date April 23, 2010

Search for publications in this journal Pharm Res

Anna Buus Frost [...] Claus Larsen et al.

PURPOSE

To establish a pharmacokinetic model for the model drug, sodium diatrizoate (DTZ), allowing joint disappearance kinetics to be estimated from...

Journal Article

Glenohumeral joint injections: a review.

Electronic publication date January 16, 2014

Search for publications in this journal Sports Health

Christopher Gross [...] Anthony Romeo et al.

CONTEXT

Intra-articular injections into the glenohumeral joint are commonly performed by musculoskeletal providers, including orthopaedic surgeons, family medicine physicians, rheumatologists, and...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances